The last two years were record-breakers for venture capital investing in Michigan-based life sciences companies, according to BioEnterprise Corp., a Cleveland-based initiative that tracks investments in healthcare and life sciences firms across the Midwest. Sixteen Michigan companies received $131.73 million in investments in 2015, including:
• Armune BioScience Inc. of Kalamazoo, commercializing a new-generation blood test to diagnose prostate cancer, received $3.54 million in Series A financing in January 2015.
• Delphinus Technologies Inc. of Plymouth, developer of a 3D imaging device to screen for breast cancer, received a $39.5 million investment in September.
• Michigan Critical Care Consultants Inc. of Dexter, developer and manufacturer of cardiopulmonary medical devices, received a $34 million investment in November.
• Tetra Discovery Partners LLC of Grand Rapids, developer of a new drug to treat Alzheimer’s disease that will go to clinical trials this year, received a $1.0 million investment in September